AGADA CEO at the World Muscle Society 2018

By October 3, 2018 No Comments

AGADA CEO Dr. Kanneboyina Nagaraju attended the World Muscle Society Congress Oct 3rd 2018 in Mendoza, Argentina. Dr.Nagaraju presented two posters on Duchenne Muscular Dystrophy

  • Vamorolone as a replacement for corticosteroids in Duchenne muscular dystrophy: phase 2a results in 48 DMD boys
  • Humoral and cell mediated immune response to new dystrophin after morpholino-induced exon skipping therapy in dystrophin-deficient mdx mice